(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page

Effects of Sterigenics Plant Shutdown on Medical Device Licences (MDL) in Canada

by Jennifer P | May 1, 2019 | Canadian Regulatory, Medical Devices, Research/Science/Technology, U.S. Regulatory

Sterigenics, an international company who provides sterilization solutions for medical devices, pharmaceutical, commercial, and food industries, has shut down its plant in Willowbrook, Illinois. The recent shutdown, which took place in February 2019, was linked to the...

Amway Launches 50 New Apps with New Digital Technology Model

by Jennifer P | Apr 24, 2019 | Cosmetics, OTC Drugs, Research/Science/Technology, U.S. Regulatory

Amway, an American multi-level marketing company that sells health, beauty, and home care products, has approached a new take on improving their business before outsider digital technology disrupts it. They recently teamed up with Texas-based software company, Kony,...

New Self-Care Framework Timeline

by Jennifer P | Apr 17, 2019 | Canadian Regulatory, Cosmetics, Natural Health Products, OTC Drugs

Health Canada is working towards improving the way self-care products (cosmetics, NHPs, and non-prescription drugs) are regulated in Canada. These changes will be implemented via the “Self-Care Framework” to regulate low-risk self care products in the same way, and...

Recyclable Cosmetic Packaging – A Step Closer to an Eco-Friendly World

by Jennifer P | Mar 19, 2019 | Cosmetics, Research/Science/Technology

As environmental awareness increases, consumers are looking for products that are sustainable for a better future. This means buying cosmetics and personal care products that are packaged in materials that are not going to end up in landfills or contribute to...

Expanded Sunscreen Pilot – Health Canada

by Jennifer P | Mar 14, 2019 | Canadian Regulatory, Cosmetics, OTC Drugs, U.S. Regulatory

Having fun in the sun is usually not a good idea without having proper sunscreen protection. Sunscreens are equipped with active ingredients that prevent damage from UV rays by using either chemical or physical UV filters. However, with most sunscreen products in...
« Older Entries

Recent Posts

  • The Sunshine Vitamin: What, Where, and How Much?
  • A Risk-Based Approach to Site License Applications
  • COVID-19 and Vitamin D: Correlation or Coincidence?
  • New Canadian Cosmetic Ingredient Hotlist Updates
  • New Cosmetic Ingredient Restrictions in the State of California

Recent Comments

    Archives

    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Regulatory
    • Cosmetics
    • European Regulatory
    • Events/Company Updates
    • Innovation
    • Innovation
    • Medical Devices
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2020 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY

    Delsie Braganza

    Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all submissions made to Health Canada and the US FDA.

    Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS). When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

     


    Jennifer Porter

    Since joining the FPR team in 2011, Jennifer has become our VP/GM managing all staff and projects in the corporate portfolio. She is responsible for finance, accounting and all aspects of IT.

    Jennifer obtained an MBA from University of Redlands, located in Southern California and a B.A. in Psychology from Hawaii Pacific University. When not supporting the needs for her clients, Jennifer enjoys golfing, live music, and traveling.